Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0009 USD | 0.00% | 0.00% | 0.00% |
Business Summary
Number of employees: 2
Managers
Managers | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 13-03-21 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 13-03-21 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 14-10-14 |
David Dickason
PRN | Corporate Officer/Principal | - | 20-09-14 |
Marc M. Radin
AUD | Comptroller/Controller/Auditor | - | 13-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 13-03-21 |
Director/Board Member | - | 23-03-21 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 13-03-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 365,418,647 | 341,184,734 ( 93.37 %) | 0 | 93.37 % |
Stock B | 0 | 37,500 | 0 | 0 |
Company contact information
RespireRx Pharmaceuticals, Inc.
126 Valley Road Suite C
07452, Glen Rock
+201 444 4947
http://www.respirerx.comSector
1st Jan change | Capi. | |
---|---|---|
0.00% | 697K | |
+8.63% | 105B | |
-0.94% | 104B | |
+5.79% | 22.94B | |
-12.90% | 22.34B | |
-6.40% | 19.25B | |
-39.98% | 17.08B | |
-9.07% | 16.96B | |
+7.47% | 14.16B | |
+39.60% | 12.63B |
- Stock Market
- Equities
- RSPI Stock
- Company RespireRx Pharmaceuticals Inc.